Thanks to its extensive technical expertise and high scientific background, along with its international network, SIIT’s License Out Division can offer its customers worldwide a high-quality, innovative product portfolio.
Most of the current turnover comes from licensed innovative products developed by its own R&D.
Strong know-how and continuous investment in clinical and technological research is the secret of the commercial success of the company’s products portfolio.
Learn more about our product pipeline